610 related articles for article (PubMed ID: 28807042)
1. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.
Hassoun A; Linden PK; Friedman B
Crit Care; 2017 Aug; 21(1):211. PubMed ID: 28807042
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Trends of Methicillin-Resistant Staphylococcus aureus in Gauteng Public Hospitals from 2009 to 2018.
Segal B; Langham A; Klevansky R; Patel N; Mokoena T; Nassiep M; Ramatlo O; Ahmad A; Duse AG
Microbiol Spectr; 2023 Aug; 11(4):e0362322. PubMed ID: 37338400
[TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.
Shane AL; Hansen NI; Stoll BJ; Bell EF; Sánchez PJ; Shankaran S; Laptook AR; Das A; Walsh MC; Hale EC; Newman NS; Schrag SJ; Higgins RD;
Pediatrics; 2012 Apr; 129(4):e914-22. PubMed ID: 22412036
[TBL] [Abstract][Full Text] [Related]
4. Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.
Furuno JP; Johnson JK; Schweizer ML; Uche A; Stine OC; Shurland SM; Forrest GN
BMC Infect Dis; 2011 Oct; 11():298. PubMed ID: 22040268
[TBL] [Abstract][Full Text] [Related]
5. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020.
Coombs GW; Daley DA; Yee NWT; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Apr; 46():. PubMed ID: 35469556
[TBL] [Abstract][Full Text] [Related]
6. Predicting methicillin resistance among community-onset Staphylococcus aureus bacteremia patients with prior healthcare-associated exposure.
Chen SY; Chiang WC; Ma MH; Hsueh PR; Chang SC; Fang CC; Chen SC; Chen WJ; Chie WC; Lai MS
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2727-36. PubMed ID: 22610613
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
Li Z; Zhuang H; Wang G; Wang H; Dong Y
BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Community-Onset
Yarovoy JY; Monte AA; Knepper BC; Young HL
West J Emerg Med; 2019 May; 20(3):438-442. PubMed ID: 31123543
[TBL] [Abstract][Full Text] [Related]
11. Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding.
Ortwine JK; Bhavan K
Hosp Pract (1995); 2018 Apr; 46(2):64-72. PubMed ID: 29400119
[TBL] [Abstract][Full Text] [Related]
12. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of Staphylococcus aureus bacteremia: a review.
Holland TL; Arnold C; Fowler VG
JAMA; 2014 Oct; 312(13):1330-41. PubMed ID: 25268440
[TBL] [Abstract][Full Text] [Related]
14. Spa type distribution in MRSA and MSSA bacteremias and association of spa clonal complexes with the clinical characteristics of bacteremia.
Jokinen E; Lindholm L; Huttunen R; Huhtala H; Vuento R; Vuopio J; Syrjänen J
Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):937-943. PubMed ID: 29428976
[TBL] [Abstract][Full Text] [Related]
15. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2022.
Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968066
[TBL] [Abstract][Full Text] [Related]
16. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
[TBL] [Abstract][Full Text] [Related]
17. Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
Kourtis AP; Hatfield K; Baggs J; Mu Y; See I; Epson E; Nadle J; Kainer MA; Dumyati G; Petit S; Ray SM; ; Ham D; Capers C; Ewing H; Coffin N; McDonald LC; Jernigan J; Cardo D
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(9):214-219. PubMed ID: 30845118
[TBL] [Abstract][Full Text] [Related]
18. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
19. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP).
Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Dec; 46():. PubMed ID: 36529133
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
